• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自患有中枢神经系统肿瘤的成年供体的胸部同种异体移植术后肿瘤传播风险——一项器官共享联合网络(UNOS)数据库研究

Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-A UNOS database study.

作者信息

Hynes Conor F, Ramakrishnan Karthik, Alfares Fahad A, Endicott Kendal M, Hammond-Jack Katrina, Zurakowski David, Jonas Richard A, Nath Dilip S

机构信息

Children's National Medical Center, Washington, USA.

出版信息

Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12919. Epub 2017 Mar 2.

DOI:10.1111/ctr.12919
PMID:28135779
Abstract

BACKGROUND

We analyzed the UNOS database to better define the risk of transmission of central nervous system (CNS) tumors from donors to adult recipients of thoracic organs.

METHODS

Data were procured from the Standard Transplant Analysis and Research dataset files. Donors with CNS tumors were identified, and recipients from these donors comprised the study group (Group I). The remaining recipients of organs from donors who did not have CNS tumors formed the control group (Group II). Incidence of recipient CNS tumors, donor-related malignancies, and overall survival were calculated and compared in addition to multivariable logistic regression.

RESULTS

A cohort of 58 314 adult thoracic organ recipients were included, of which 337 received organs from donors who had documented CNS tumors (Group I). None of these recipients developed CNS tumors at a median follow-up of 72 months (IR: 30-130 months). Although overall mortality in terms of the percentage was higher in Group I than Group II (163/320=51% vs 22 123/52 691=42%), Kaplan-Meier curves indicate no significant difference in the time to death between the two groups (P=.92).

CONCLUSIONS

There is little risk of transmission of the common nonaggressive CNS tumors to recipients of thoracic organs.

摘要

背景

我们分析了器官共享联合网络(UNOS)数据库,以更好地确定中枢神经系统(CNS)肿瘤从供体传播至成年胸段器官受体的风险。

方法

数据取自标准移植分析与研究数据集文件。识别出患有中枢神经系统肿瘤的供体,来自这些供体的受体组成研究组(I组)。来自没有中枢神经系统肿瘤的供体的其余器官受体形成对照组(II组)。计算并比较受体中枢神经系统肿瘤的发病率、与供体相关的恶性肿瘤以及总生存率,并进行多变量逻辑回归分析。

结果

纳入了58314名成年胸段器官受体队列,其中337人接受了来自有记录的中枢神经系统肿瘤供体的器官(I组)。在中位随访72个月(范围:30 - 130个月)时,这些受体均未发生中枢神经系统肿瘤。尽管I组的总体死亡率百分比高于II组(163/320 = 51% 对比 22123/52691 = 42%),但Kaplan-Meier曲线表明两组之间的死亡时间无显著差异(P = 0.92)。

结论

常见的非侵袭性中枢神经系统肿瘤传播至胸段器官受体的风险很小。

相似文献

1
Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-A UNOS database study.来自患有中枢神经系统肿瘤的成年供体的胸部同种异体移植术后肿瘤传播风险——一项器官共享联合网络(UNOS)数据库研究
Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12919. Epub 2017 Mar 2.
2
Transplant tumor registry: donors with central nervous system tumors1.移植肿瘤登记处:患有中枢神经系统肿瘤的供体1。
Transplantation. 2002 Feb 27;73(4):579-82. doi: 10.1097/00007890-200202270-00017.
3
Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes.肺和心脏供体的双重获取不会对肺移植结果产生负面影响。
J Surg Res. 2021 Mar;259:106-113. doi: 10.1016/j.jss.2020.11.036. Epub 2020 Dec 3.
4
Impact of donor age on survival after heart transplantation: an analysis of the United Network for Organ Sharing (UNOS) registry.供体年龄对心脏移植术后生存率的影响:器官共享联合网络(UNOS)登记处分析
J Card Surg. 2014 Sep;29(5):723-8. doi: 10.1111/jocs.12406. Epub 2014 Jul 19.
5
Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.“高风险”供心对移植结局的影响:倾向评分匹配分析。
J Thorac Cardiovasc Surg. 2019 Feb;157(2):603-610. doi: 10.1016/j.jtcvs.2018.08.120. Epub 2018 Oct 19.
6
Interaction of older donor age and survival after weight-matched pediatric heart transplantation.老年供体年龄与体重匹配的儿科心脏移植后存活的相互作用。
J Heart Lung Transplant. 2017 May;36(5):554-558. doi: 10.1016/j.healun.2016.11.009. Epub 2016 Dec 1.
7
Safety of Donation From Brain-dead Organ Donors With Central Nervous System Tumors: Analysis of Transplantation Outcomes in Korea.脑死亡器官捐献者伴中枢神经系统肿瘤的捐献安全性:韩国移植结局分析。
Transplantation. 2020 Mar;104(3):460-466. doi: 10.1097/TP.0000000000002994.
8
Advising potential recipients on the use of organs from donors with primary central nervous system tumors.就原发性中枢神经系统肿瘤供者器官的使用向潜在受者提供咨询。
Transplantation. 2012 Feb 27;93(4):348-53. doi: 10.1097/TP.0b013e31823f7f47.
9
Does Lung Donation by Heart Donors Have an Impact on Survival in Heart Transplant Recipients?心脏捐献者的肺脏捐献对心脏移植受者的生存有影响吗?
Am J Transplant. 2017 Feb;17(2):506-511. doi: 10.1111/ajt.13981. Epub 2016 Aug 25.
10
Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for thoracic organ transplantation.全球胸器官移植:来自器官共享联合网络/国际心肺移植学会胸器官移植国际登记处的报告
Clin Transpl. 1997:29-43.

引用本文的文献

1
Donors With Previous Malignancy: When Is It Safe to Proceed With Organ Transplantation?有既往恶性肿瘤病史的供体:何时进行器官移植才安全?
Transpl Int. 2025 Jan 24;38:13716. doi: 10.3389/ti.2025.13716. eCollection 2025.